Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideRMDResMed|
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | RMD | TMO |
|---|
| Close | 228.25 | 648.43 |
| Market Cap | $32.9B | $240B |
| 1M | +3.58% | +10.75% |
| P/E (TTM) | 21.6 | 34.4 |
| Forward P/E | 17.4 | 21.8 |
| P/E 5-Yr Percentile | 10 | 65 |
| P/S | 5.8 | 5.2 |
| P/B | 5.0 | 4.6 |
| Dividend Yield | 1.25% | 0.29% |
| Latest Quarter Revenue | $1.5B | $12.0B |
| Revenue YoY | +8.6% | +10.5% |
| Gross Margin | 58.8% | — |
| Latest Quarter EPS | 2.64 | 4.68 |
| Avg Post-Earnings Move | ±2.6% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.19% | 2.36% |
| 90-Day Net Insider Buying | −$5.3M | −$38.9M |
RMD · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
